Efficient prediction of drug-drug interaction using deep learning models.

A drug-drug interaction or drug synergy is extensively utilised for cancer treatment. However, prediction of drug-drug interaction is defined as an ill-posed problem, because manual testing is only implementable on small group of drugs. Predicting the drug-drug interaction score has been a popular research topic recently. Recently many machine learning models have proposed in the literature to predict the drug-drug interaction score efficiently. However, these models suffer from the over-fitting issue. Therefore, these models are not so-effective for predicting the drug-drug interaction score. In this work, an integrated convolutional mixture density recurrent neural network is proposed and implemented. The proposed model integrates convolutional neural networks, recurrent neural networks and mixture density networks. Extensive comparative analysis reveals that the proposed model significantly outperforms the competitive models.

[1]  Larry Rubinstein,et al.  The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity. , 2017, Cancer research.

[2]  Gang Wang,et al.  A novel bankruptcy prediction model based on an adaptive fuzzy k-nearest neighbor method , 2011, Knowl. Based Syst..

[3]  Fuji Ren,et al.  Drug-Drug Interaction Extraction Based on Transfer Weight Matrix and Memory Network , 2019, IEEE Access.

[4]  Jeffrey L. Elman,et al.  Finding Structure in Time , 1990, Cogn. Sci..

[5]  Pingzhao Hu,et al.  Predicting drug-target interaction network using deep learning model , 2019, Comput. Biol. Chem..

[6]  Luonan Chen,et al.  Drug repositioning framework by incorporating functional information. , 2013, IET systems biology.

[7]  Louiqa Raschid,et al.  Ieee/acm Transactions on Computational Biology and Bioinformatics 1 Network-based Drug-target Interaction Prediction with Probabilistic Soft Logic , 2022 .

[8]  Menglan Cai,et al.  Drug repositioning via matrix completion with multi‐view side information , 2019, IET systems biology.

[9]  A. Fajmut,et al.  Dynamic model of eicosanoid production with special reference to non-steroidal anti-inflammatory drug-triggered hypersensitivity. , 2015, IET systems biology.

[10]  R. Shoemaker The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[11]  Gerasimos Rigatos,et al.  Flatness-based control approach to drug infusion for cardiac function regulation. , 2017, IET systems biology.

[13]  Jue Wang,et al.  A general soft method for learning SVM classifiers with L1-norm penalty , 2008, Pattern Recognit..

[14]  H. Zohoor,et al.  Robust adaptive Lyapunov‐based control of hepatitis B infection , 2017, IET systems biology.

[15]  Yi-Ping Phoebe Chen,et al.  Machine learning on adverse drug reactions for pharmacovigilance. , 2019, Drug discovery today.

[16]  Aamer Iqbal Bhatti,et al.  Sliding mode controller–observer pair for p53 pathway , 2019, IET systems biology.

[17]  Dilbag Singh,et al.  Improved Particle Swarm Optimization Based Adaptive Neuro-Fuzzy Inference System for Benzene Detection , 2018 .

[18]  D Riley,et al.  Modelling and analysis of the sugar cataract development process using stochastic hybrid systems. , 2009, IET systems biology.

[19]  C. Chung,et al.  Constant drug dose in human immuno-deficiency virus-infected patients to induce long-term non-progressor status: bifurcation and controllability approach. , 2013, IET systems biology.

[20]  Jürgen Schmidhuber,et al.  Framewise phoneme classification with bidirectional LSTM and other neural network architectures , 2005, Neural Networks.

[21]  Shital A. Raut,et al.  Mining conditions specific hub genes from RNA‐Seq gene‐expression data via biclustering and their application to drug discovery , 2019, IET systems biology.

[22]  Manjit Kaur,et al.  Multi-objective differential evolution based random forest for e-health applications , 2019, Modern Physics Letters B.

[23]  Beiji Zou,et al.  Prediction of Drug-Drug Interactions Based on Multi-layer Feature Selection and Data Balance , 2017 .

[24]  H. Zou,et al.  The doubly regularized support vector machine , 2006 .

[25]  Luonan Chen,et al.  Detecting drug targets with minimum side effects in metabolic networks. , 2009, IET systems biology.

[26]  Limin Li,et al.  MPGraph: multi-view penalised graph clustering for predicting drug-target interactions. , 2014, IET systems biology.

[27]  B. Ribba,et al.  Chemotherapy may be delivered based on an integrated view of tumour dynamics. , 2009, IET systems biology.

[28]  Deyu Zhou,et al.  Position-aware deep multi-task learning for drug-drug interaction extraction , 2018, Artif. Intell. Medicine.

[29]  K. Cahill,et al.  Cell-penetrating peptides, electroporation and drug delivery. , 2010, IET systems biology.

[30]  H. Yue,et al.  Investigating receptor enzyme activity using time-scale analysis. , 2015, IET systems biology.

[31]  Avi Ma’ayan Network integration and graph analysis in mammalian molecular systems biology. , 2008, IET systems biology.

[32]  Wei Zheng,et al.  Leveraging Biomedical Resources in Bi-LSTM for Drug-Drug Interaction Extraction , 2018, IEEE Access.

[33]  T. V. Geetha,et al.  A meta-learning framework using representation learning to predict drug-drug interaction , 2018, J. Biomed. Informatics.

[34]  Yanlin Chen,et al.  SFLLN: A sparse feature learning ensemble method with linear neighborhood regularization for predicting drug-drug interactions , 2019, Inf. Sci..